Skip to main content

Publikationer Multipel skleros

Vetenskapliga artiklar

Publikationslista Svenska neuroregister-Multipel skleros 2003-2016
 

Poster urval (Pdf)

2017
Real-time monitoring of MS-immunotherapy discontinuation, switching, and restarting with a Visualisation and Analysis Platform (VAP) implemented in the Swedish MS-Registry. Hagel E, Hillert J, Stawiarz L (ECTRIMS conference Paris 2017)

2016
National, real-time monitoring of MS immunotherapy patterns with Visualisation and Analysis Platform (VAP) implemented in Swedish MS Registry Stawiarz L. (ECTRIMS conference London 2016)

Adaptation and Preliminary Testing of Six Neuro-QoL Item banks for use in the Swedish Neuro-registries/ Multiple Sclerosis registry (NEUROreg/MSreg) Chaplin J.(ECTRIMS conference London 2016)

Real-time monitoring of Multiple Sclerosis care guidelines with clinical endpoints and computer-supported PROs: The Swedish MS registry. Hillert J. (Svenska Kvalitetsregisterkonferensen Göteborg 2016)

2015
Functional watch, a real time, graphical composite representation of MS patients health status, as a deciscion support tool in daily clinical practise, Stawiarz L. (ECTRIMS conference Barcelona 2015)

Visualiserings- och analysplattform (VAP) för Multipel skleros i Svenska neuroregister, Stawiarz L. (Svenska Kvalitetsregisterkonferensen Jönköping 2015)

2014
Visualization and Analysis Platform in the Swedish National MS Registry for Real-Time Data Feedback. Stawiarz L. (ACTRIMS-ECTRIMS conference Boston USA 2014)
 

Artiklar urval (Pdf)

2017
Feltelius Nils, Gedeborg Rolf, Holm Lennart och Zethelius Björn
Utility of registries for post-marketing evaluation of medicines. A survey of Swedish health care quality registries from a regulatory perspective,
Uppsala Journal of Medical Sciences, March 2017, 122:2, 136-147

2016
Manouchehrinia A, Beiki O, Hillert J, Clinical course of multiple sclerosis: A nationwide cohort study. Multiple Sclerosis Journal 2016

Westerlind H, Stawiarz L, Fink K, Hillert J, Manouchehrinia A. A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Multiple Sclerosis Journal, 2016, Vol.22(8), pp.1071-1079



2015

The Swedish MS registry – clinical support tool and scientific resource, Hillert J, Stawiarz L, (Acta Neurologica Scandinavica juni/juli 2015)

 

2014
High nationwide incidence of Multiple Sclerosis in Sweden. Ahlgren C. (Plos one September 2014)

New data identify an increasing sex ratio of multiple sclerosis in Sweden. Westerlind H. (Mult Scler. 2014 May 19, E-pub ahead of print)

Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg). Boström I. (Mult Scler. 2014 Apr;20(4):513-4)

Modest familiar risks for multiple sclerisis: a registry-based study of the population of Sweden. Westerlind H. (Brain 2014;137 770-778)

Registerbaserad studie visar på låg familjär risk för MS. Westerlind H. (Neurologi i Sverige 2-2014)

2013
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Tedeholm H. (Mult Scler. 2013 May;19(6):765-74)

Kvalitetssäkring av MS med hjälp av Svenska MS-registret. Svenningsson A. (Best Practice December 2013) 

2012
From the Gothenburg cohort to the Swedish multiple sclerosis registry. Andersen O. (Acta Neurol Scand 2012: 126 (Suppl. 195): 13–19)

2011
High nationwide prevalence of multple scleros in Sweden. Ahlgren C. (Mult Scler. 2011 Aug;17(8):901-8)

2008
Modelling the cost-effectiveness of a new treatment for MS (Natalizmab) compared with current standard practice in Sweden. Kobelt G (Mult Scler. 2008;14:679-690)
 

Rapporter urval (Pdf)

2009
Relationships of geochemistry and multiple sclerosis. Eliaeson K. (IVL Svenska Miljöinstitutets rapport, B1824 December 2009)